Rochman et al (J Clin Make investments 2025;135:e194080; https://doi.org/10.1172/JCI194080) developed a novel therapeutic technique to restrict TH2 cell immunity by administration of allergen-encoding mRNA fused to lipid nanoparticles (mRNA-LNP). Immunization with mRNA-LNPs enhanced TH1 and allergen-specific IgG responses whereas concurrently impairing allergen-specific IgE, TH2, and TH17 cell responses. Moreover, immunopathology was ameliorated in each preventive and established experimental murine fashions of allergic airway irritation.
Trending Merchandise
Added to wishlistRemoved from wishlist 0
$25.00
Added to wishlistRemoved from wishlist 0
$29.71
Added to wishlistRemoved from wishlist 0
$32.99
Added to wishlistRemoved from wishlist 0
$13.99
Added to wishlistRemoved from wishlist 0
$17.99
Added to wishlistRemoved from wishlist 0
$7.85
Added to wishlistRemoved from wishlist 0
$8.83
Added to wishlistRemoved from wishlist 0
$45.40
Added to wishlistRemoved from wishlist 0
$9.99
Carlyle Cat’s Claw Capsules 1000mg | 180 Count | Uncaria Tomentosa | Non-GMO, Gluten Free Supplement
Added to wishlistRemoved from wishlist 0
$15.28

